Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $241,928 (100.0% shares, 0.0% debt)

Holdings (9)

BVS BIOVENTUS 34.1%

Value ($000) $82,500 Shares 12,096,702 Est. Cost $14.24 Unrealized -28.4%

MDXG MIMEDX GROUP, INC. 33.6%

Value ($000) $81,252 Shares 23,415,584 Est. Cost $7.34 Unrealized -46.7%

EYPT EYEPOINT PHARMACEUTICALS INC 13.6%

Value ($000) $32,983 Shares 4,190,921 Est. Cost $4.68 Unrealized +114.8%

TELA TELA BIO, INC. 10.3%

Value ($000) $24,996 Shares 3,565,709 Est. Cost $12.35 Unrealized -32.8%

— VENUS CONCEPT, INC. 3.1%

Value ($000) $7,515 Shares 21,169,457 Est. Cost $2.99 Unrealized —

— REVANCE THERAPEUTICS INC 2.6%

Value ($000) $6,317 Shares 457,085 Est. Cost $31.50 Unrealized —

— SONENDO INC 1.4%

Value ($000) $3,427 Shares 1,992,526 Est. Cost $5.76 Unrealized —

MNOV MEDICINOVA INC 1.2%

Value ($000) $2,798 Shares 1,105,941 Est. Cost $2.95 Unrealized -11.5%

— CATALYST BIOSCIENCES INC 0.1%

Value ($000) $140 Shares 78,622 Est. Cost $7.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BVS	BIOVENTUS	12,096,702	$82,500	34.1%	$14.24	-28.4%	COM CL A	09075A108
MDXG	MIMEDX GROUP, INC.	23,415,584	$81,252	33.6%	$7.34	-46.7%	COM	602496101
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$32,983	13.6%	$4.68	+114.8%	COM NEW	30233G209
TELA	TELA BIO, INC.	3,565,709	$24,996	10.3%	$12.35	-32.8%	COM	872381108
—	VENUS CONCEPT, INC.	21,169,457	$7,515	3.1%	$2.99	—	COM	92332W105
—	REVANCE THERAPEUTICS INC	457,085	$6,317	2.6%	$31.50	—	COM	761330109
—	SONENDO INC	1,992,526	$3,427	1.4%	$5.76	—	COM	835431107
MNOV	MEDICINOVA INC	1,105,941	$2,798	1.2%	$2.95	-11.5%	COM NEW	58468P206
—	CATALYST BIOSCIENCES INC	78,622	$140	0.1%	$7.36	—	COM NEW	14888D208